HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC approves Whole Foods order

This article was originally published in The Rose Sheet

Executive Summary

Whole Foods Market will divest 13 operating and 19 closed locations as part of a final consent order issued May 28 by the Federal Trade Commission. The Austin, Texas-based premium grocery chain settled with the agency after FTC pursued an antitrust case against the company's 2007 acquisition of competitor Wild Oats, claiming the merger limits competition in the "premium, natural and organic supermarket segment" (1"The Rose Sheet" Aug. 18, 2008, p. 9). The final order, which the four commissioners unanimously approved, says an appointed divestiture trustee will have six months to complete the divestiture

You may also be interested in...



Whole Foods Merger Ruling Could “Embolden” Antitrust Activity – Attorney

An appeals court's questions about a merger in a key market for natural and organic personal-care products manufacturers - the Whole Foods-Wild Oats deal - may impede similar deals across all U.S. industries, an antitrust law expert says

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016199

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel